advertisement
Abstract #20616 Published in IGR 10-1
Erythema multiforme after use of topical dorzolamide
Munshi V; Ahluwalia HJournal of Ocular Pharmacology and Therapeutics 2008; 24: 91-93
Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide.
Dr. V. Munshi, Eye Department, University Hospitals of Coventry and Warwickshire NHS Trust, 173, Blackhaynes Road, Coventry, 629 4re, United Kingdom. vineetamunshi@hotmail.com
Classification:
11.5.2 Topical (Part of: 11 Medical treatment > 11.5 Carbonic anhydrase inhibitors)
